APLTApplied Therapeutics Inc.

Nasdaq www.appliedtherapeutics.com


$ 7.86 $ 3.20 (68.82 %)    

Wednesday, 18-Sep-2024 15:59:59 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 7.85
$ 6.55
$ 7.84 x 100
$ 7.87 x 158
$ 6.31 - $ 8.40
$ 1.79 - $ 9.39
50,993,738
na
901.54M
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-06-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-10-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 03-18-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-11-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-13-2020 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-12-2019 06-30-2019 10-Q
22 06-21-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 russell-2000-outpaces-sp-500-as-small-caps-anticipate-feds-interest-rate-move

Small-cap stocks are surging ahead of the expected interest rate cut by the Federal Reserve, outperforming their larger-cap cou...

 applied-therapeutics-stock-soars-as-fda-scraps-panel-meeting-for-its-inherited-metabolic-disorder-drug

Applied Therapeutics stock rises as the FDA no longer requires an Advisory Committee meeting, keeping the Priority Review on tr...

Core News & Articles

LUNR: 70% | Intuitive Machines shares are trading higher after the company announced it was awarded a NASA Near Space Network c...

 citigroup-maintains-buy-on-applied-therapeutics-raises-price-target-to-8

Citigroup analyst Yigal Nochomovitz maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from...

 rare-disease-focused-applied-therapeutics-lead-candidate-govorestat-has-blockbuster-potential-analyst-sees-140-stock-upside

William Blair has initiated coverage on Applied Therapeutics highlighting its focus on rare diseases such as galactosemia, SORD...

 william-blair-initiates-coverage-on-applied-therapeutics-with-outperform-rating

William Blair analyst Tim Lugo initiates coverage on Applied Therapeutics (NASDAQ:APLT) with a Outperform rating.

 rbc-capital-reiterates-outperform-on-applied-therapeutics-maintains-12-price-target

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics (NASDAQ:APLT) with a Outperform and maintains $12 price t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION